DESTINA GENOMICS

DestiNA Genomics Ltd (DGL) is a University of Edinburgh spin-out company, formed to commercialise a revolutionary chemical based system for detecting nucleic acids and single nucleotide polymorphisms (SNP’s). DGL has entered into an exclusive Licence Agreement with the University of Edinburgh, covering the development and commercialisation arising from the patent “Nucleobase Characterisation”. The technology is unique and distinguishable from ALL existing enzymatic methods of nucleic acid ... analysis. DGL intends to develop and launch a completely ‘PCR free’ system for nucleic acid analysis, using the unique properties of the nucleobase chemistry. In particular, DGL has identified that its reagents are particularly suited for direct detection of micro-RNA’s.DestiNA is working with trade partners to integrate their technology within colorimetric, fluorescent and electrochemical-based detection platforms. DestiNA Genomics Ltd has incorporated a Spanish company called DestiNA Genomica SL with the goal of exploit our technology in Spain with different partners such as Master Diagnostica. DestiNA Genomica SL. was awarded a grant from the Technological Fund of Invest in Spain (1-2011/55 €239,000). The Technological Fund of Invest in Spain is a special area of ERDF funds from the European Union created to promote business R&D&I in Spain for the 2007-2013 period.

#SimilarOrganizations #People #Financial #Website #More

DESTINA GENOMICS

Social Links:

Twitter

Industry:

Biotechnology Genetics

Founded:

2010-01-01

Address:

Edinburgh, Edinburgh, City Of, United Kingdom

Country:

United Kingdom

Website Url:

http://www.destinagenomics.com

Total Employee:

11+

Status:

Active

Contact:

+44 (0)162 082 2611

Email Addresses:

[email protected]

Total Funding:

1.2 M EUR

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics

Similar Organizations

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system

Current Employees Featured

hugh-ilyine_image

Hugh Ilyine
Hugh Ilyine Chief Executive Officer @ DestiNA Genomics
Chief Executive Officer
2010-11-01

juan-j-diaz-mochon_image

Juan J. Diaz Mochon
Juan J. Diaz Mochon Founder & CSO @ DestiNA Genomics
Founder & CSO
2010-09-01

Founder

juan-j-diaz-mochon_image

Juan J. Diaz Mochon

Investors List

vitro-group_image

Official Site Inspections

http://www.destinagenomics.com

Host Informations
Whois Informations

Loading ...